1. WNK1 kinase is essential for insulin‐stimulated GLUT4 trafficking in skeletal muscle
- Author
-
Ji Hee Kim, Jae Seung Chang, In Deok Kong, Hanul Kim, Seung Kuy Cha, Kyu Sang Park, and Kyu Hee Hwang
- Subjects
0301 basic medicine ,insulin ,endocrine system diseases ,medicine.medical_treatment ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,Insulin resistance ,trafficking ,medicine ,skeletal muscle ,WNK1 ,Research Articles ,PI3K/AKT/mTOR pathway ,biology ,Chemistry ,Kinase ,Insulin ,nutritional and metabolic diseases ,Skeletal muscle ,medicine.disease ,Cell biology ,Insulin receptor ,030104 developmental biology ,medicine.anatomical_structure ,diabetes mellitus ,biology.protein ,Phosphorylation ,GLUT4 ,030217 neurology & neurosurgery ,Research Article - Abstract
With‐no‐lysine 1 (WNK1) kinase is a substrate of the insulin receptor/Akt pathway. Impaired insulin signaling in skeletal muscle disturbs glucose transporter 4 (GLUT4) translocation associated with the onset of type 2 diabetes (T2D). WNK1 is highly expressed in skeletal muscle. However, it is currently unknown how insulin signaling targeting WNK1 regulates GLUT4 trafficking in skeletal muscle, and whether this regulation is perturbed in T2D. Hereby, we show that insulin phosphorylates WNK1 at its activating site via a phosphatidylinositol 3‐kinase‐dependent mechanism. WNK1 promotes the cell surface abundance of GLUT4 via regulating TBC1D4. Of note, we observed insulin resistance and decreased WNK1 phosphorylation in T2D db/db mice as compared to the control mice. These results provide a new perspective on WNK1 function in the pathogenesis of hyperglycemia in T2D.
- Published
- 2018
- Full Text
- View/download PDF